| Name | Title | Contact Details |
|---|
Monroe County Medical Center is a Tompkinsville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The HCA Physician Services Group, a part of the HCA family, is focused on implementing innovative, value-added solutions that help our physicians deliver high quality, cost effective healthcare and support HCA`s commitment to the care and improvement of human life. As the physician solution for HCA, the Physician Services Group makes it easier for physicians to practice medicine by reducing the burdens of managing an independent practice and infusing the best clinical and operational standards in every office. The Physician Services Group is always looking for great people who are passionate about caring for human life. We are looking for experienced health care executives, skilled operators, area and market managers, practice managers, accountants, coders, business analysts, charge entry specialists, medical assistants and all around leaders ready for their next great opportunity.
Heritage Living Ctr is a Ashland, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glendive Medical Center (GMC) is committed to caring, healing and a healthier community. As a leading provider healthcare services in eastern Montana and western North Dakota, our entire organization is committed to providing high quality care in a safe
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.